Shares in Alcon fell as much as 11.6% on Wednesday after the Swiss-American eye care group cut its 2025 sales outlook late on ...

The company said it expects a $100 million hit from tariffs this year.

Swiss-American eye care firm Alcon Inc (NYSE:ALC) stock slumped on Wednesday after the company cut its 2025 outlook late on ...

Alcon remains a leader in eye care, benefiting from strong market positioning and long-term industry tailwinds. Read the ...

Alcon (NYSE:ALC) is down ~9% in Wednesday trading after releasing Q2 financial results after Tuesday's closing bell that ...

Traders braced for earnings from big-name retailers Lowe’s and Target. Palantir and Intel stocks fell as the tech selloff ...

Alcon showcases new data at APACRS 2025, emphasizing advancements in IOL technology and surgical precision for improved ...

We recently published 10 Stocks Crash as AI Glow Fades. Alcon Inc. (NYSE:ALC) is one of Wednesday’s worst performers. Shares of Alcon Inc. snapped a six-day winning streak on Wednesday, losing 10.07 ...

For almost four decades, Tom McDonald was a part of the team at Fort Worth-born Alcon, which continues to make innovative moves in the world of eyecare products. He recaps the company’s first five ...

Alcon (NYSE:ALC) stock continues to decline as J.P. Morgan downgrades the company following mixed Q2 2025 results and lowered sales guidance. Read more here.

Q2 2025 Management View CEO David J. Endicott opened by highlighting Alcon's transition into "an exciting phase" characterized by several major product launches gaining traction. Endicott stated, "Our ...

Alcon affirmed fiscal year 2025 adjusted earnings of $3.05-$3.15 versus consensus of $3.12. The company lowered 2025 sales guidance from $10.4 billion-$10.5 billion to $10.3 billion-$10.4 billion, ...